Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Clarithromycin on Brensocatib PK
NCT05965570Phase 1Completed
- Sponsor
- Insmed Incorporated
- Start
- Jul 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of brensocatib in bronchiectasis, sponsored by Insmed Incorporated. Primary endpoint: Area Under the Plasma Concentration-time Curve. Started Jul 2023; status: completed.
02
Drugs
brensocatib
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT05965570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05965570.